TruSight Oncology Product Family

Advanced genomic analysis platform enabling sequencing and interpretation of genetic material for research and diagnostic applications. Supports precision medicine initiatives and personalized healthcare approaches.

An automated next-generation sequencing (NGS) platform designed to streamline oncology sequencing workflows. Clear Dx® automates key steps in library preparation and sequencing setup, reducing hands-on time while improving consistency and reproducibility across complex genomic assays. The platform supports a wide range of oncology research workflows, including targeted sequencing of solid tumor samples, liquid biopsy applications, and fusion detection assays, and integrates with secondary and tertiary bioinformatics platforms for variant analysis, interpretation, and results reporting.

Cutting-edge genomics solutions for molecular research and diagnostic applications enabling advanced scientific analysis.

Automated NGS platform for oncology research and testing, developed in collaboration with Labcorp. Streamlines genomic workflows with scalable, in-house testing capabilities.

Advanced testing platform spanning whole genome sequencing, whole exome sequencing, pharmacogenomics, microbiome analysis, and proteomics. Provides clinical-grade multiomics data acquisition under one integrated platform.

Advanced sequencing platform enabling detection of complex genetic targets including difficult-to-sequence regions. Supports consolidated workflows for inherited genetics and oncology applications.

The IntelliPrep TRIO 240 is a fully automated sample preparation system that performs nucleic acid extraction, quantification, normalization, and PCR assay setup—all in one instrument. Designed to reduce hands-on time and tedious manual steps, TRIO 240 enables efficient processing of FFPE, plasma, and other clinical samples for downstream diagnostics assays.

Next-generation sequencing platform for comprehensive genetic and metabolic disease screening. Suitable for newborn screening, genetic disease diagnosis, and large-scale genomic analysis applications.

Advanced next-generation sequencing technology platform for professional diagnostic and research use. The system provides high-throughput genetic sequencing capabilities for medical applications.

A next-generation sequencing platform for clinical applications with flexible library preparation options (mid or high throughput). It offers convenient operation with total hands-on time under 45 minutes and rapid sequencing in 2.5 to 24 hours with adjustable reading lengths of 150bp, 300bp, or 600bp. The system can achieve detection sensitivity starting from as low as 10ng of nucleic acid and provides integrated data processing with the GENETRON S5 Server system. It has broad applications across tumor genomics, hereditary disease detection, microbial identification, and genetic combination testing.

Next-generation sequencing platform for large-scale genomic analysis and molecular testing. Enables comprehensive sequencing workflows for diagnostic and research applications.

Complete spatial biology workflows for tumor microenvironment profiling without significant capital expenditure. Integrates tissue analysis with molecular detection capabilities.